Fecal Microbiota Transplantation to Reverse Host-Related Determinants of Resistance to Anticancer Immunotherapy

Gastroenterology. 2024 Mar;166(3):535. doi: 10.1053/j.gastro.2023.12.001. Epub 2023 Dec 6.

Authors

Paolo Davide D'arienzo¹, David J Pinato²

Affiliations

¹ Department of Cancer Services, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
² Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

PMID: 38065343
DOI: 10.1053/j.gastro.2023.12.001

No abstract available

Publication types

Comment

MeSH terms

Fecal Microbiota Transplantation*
Gastrointestinal Microbiome*
Humans
Immunotherapy